Formulation of Persea americana seed extract into tablet dosage

Main Article Content

NIJOPHASR
Majekodunmi S. O.
Ekpenyong O.

Abstract

Formulation of ethanol seed extract of Persea americana Mill (Family Lauraceae) into tablet dosage form was investigated. Formulation into tablets was done by direct compression using lactose and microcrystalline cellulose (Avicel) as directly compressible diluent and wet granulation using 4% solutions of gelatin and polyvinyl pyrrolidone (PVP) as binders. Tablets were compressed at 10, 15 and 20 kN and later subjected to tablet quality testing procedures. The mechanical properties of the tablets were assessed using crushing strength (CS) and friability (F) and the crushing strength – friability ratio (CSFR) while drug release properties were evaluated using disintegration and dissolution times. There were statistically significant (p < 0.01) differences in the crushing strength (CS) values and drug release properties of P. americana prepared by both methods. Tablets containing Avicel produced better mechanical properties than tablets containing lactose. Tablets containing PVP as binder possessed better and more consistent release properties than tablets containing gelatin. Tablets produced by direct compression possessed better mechanical and release properties than tablets produced by wet granulation. The method of preparation of the P. americana tablets needs to be carefully selected to ensure the production of tablets with adequate bond strength and the same time release its active contents for pharmacologic action. 

Downloads

Download data is not yet available.

Article Details

How to Cite
NIJOPHASR, S. O., M., & O., E. (2020). Formulation of Persea americana seed extract into tablet dosage. Nigerian Journal of Pharmaceutical and Applied Science Research, 1(2). Retrieved from http://mail.nijophasr.net/index.php/nijophasr/article/view/14
Section
Articles

References

Adeyemi, O. O., Okpo, S. O., Ogunti, O. O. (2002): Analgesic and antiinflammatory effects of some aqueous extracts of leaves of Persea Americana Mill (Lauraceae). Fitoterapia, 73: 375 - 380 British Pharmacopoeia, 1998. HMSO, London. P. A262. Cox,

P.A. and Balick, M.J.(1994): The Ethnobotanical approach to drug discovery.Scientific American, 270: 60.

Majekodunmi, S. O., Odeku, O. A., Adegoke, O. A. (2008): Formulation of the extract of the stem bark of Alstonia boonei as tablet dosage form. Tropl J. of Pharm. Res, 7 (1): 870-880

Odugbemi, T.O. (2008): A textbook of Medicinal Plants from Nigeria. Tolu Odugbemi, p.64-69.

Odeku O.A. and Fell JT. (2006): Effects of the method of preparation on the compression, mechanical and release properties of khaya gum matrices. Pharm Dev Tech.; 11:435441.

Odeku O.A. and Itiola O.A. (1998): Evaluation of khaya gum as a binder in a paracetamol tablet formulation. Pharm. Pharmacol. Commun.; 4:183188.

Pamplona-Rogers (1999): The Medicinal Plants. In: Encyclopedia of Medicinal Plants(1). (Ed) Safeliz, Madrid, pp. 5.

Sofowora, A. (1993): Medicinal Plants and Traditional Medicine in Africa. Spectrum Books, Lagos The Lancet (1994):Pharmaceuticals from plants: Great Potential, Few Funds(Editorial) Lancet 343: pp. 1513. Vinokurova, N.G,

Zelenkova, N.F, Baskunov, B.P., Arinbasarov, M.U. (2001): Determination of Diketopiperazine Alkaloids of the Roquefortine Group by UV Spectroscopy, ThinLayer Chromatography, and HighPerformance Liquid Chromatography. J. Anal Chem,56 (3): 258–262.